Tasyurek, H. M. Et Al. 2018. Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes. HUMAN GENE THERAPY , vol.29, no.7 , 802-815.

Tasyurek, H. M., Altunbas, H. A., BALCI, M. K., Griffith, T. S., & ŞANLIOĞLU, S., (2018). Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes. HUMAN GENE THERAPY , vol.29, no.7, 802-815.

Tasyurek, Hale Et Al. "Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes," HUMAN GENE THERAPY , vol.29, no.7, 802-815, 2018

Tasyurek, Hale M. Et Al. "Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes." HUMAN GENE THERAPY , vol.29, no.7, pp.802-815, 2018

Tasyurek, H. M. Et Al. (2018) . "Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes." HUMAN GENE THERAPY , vol.29, no.7, pp.802-815.

@article{article, author={Hale M. Tasyurek Et Al. }, title={Therapeutic Potential of Lentivirus-Mediated Glucagon-Like Peptide-1 Gene Therapy for Diabetes}, journal={HUMAN GENE THERAPY}, year=2018, pages={802-815} }